Anti-intraocular hypertension drugs are medications that can treat high intraocular pressure.
This report contains market size and forecasts of Anti-intraocular Hypertension Drugs in global, including the following market information:
Global Anti-intraocular Hypertension Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-intraocular Hypertension Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-intraocular Hypertension Drugs companies in 2021 (%)
The global Anti-intraocular Hypertension Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Alpha Agonist Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-intraocular Hypertension Drugs include Allergen, Novartis, Santen Pharmaceutical, Akorn, AGC Chemicals, Pfizer, Emmennar, Baush Health Companies and Aerie Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-intraocular Hypertension Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-intraocular Hypertension Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-intraocular Hypertension Drugs Market Segment Percentages, by Type, 2021 (%)
Alpha Agonist
Beta Blockers
Prostaglandin Analogs
Others
Global Anti-intraocular Hypertension Drugs Market, by Distribution Channel, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-intraocular Hypertension Drugs Market Segment Percentages, by Distribution Channel, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Anti-intraocular Hypertension Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-intraocular Hypertension Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-intraocular Hypertension Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-intraocular Hypertension Drugs revenues share in global market, 2021 (%)
Key companies Anti-intraocular Hypertension Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anti-intraocular Hypertension Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergen
Novartis
Santen Pharmaceutical
Akorn
AGC Chemicals
Pfizer
Emmennar
Baush Health Companies
Aerie Pharmaceuticals
Senju Pharmaceuticals
Zydus Cadila
Johnson
Merck
China Resources Zizhu Pharmaceutical
Sun Ophthalmics
Bayer
Hengrui Pharma
Ausun Pharmaceutical